InvestorsHub Logo
Followers 30
Posts 2200
Boards Moderated 0
Alias Born 12/13/2016

Re: crescentmotor post# 367340

Friday, 07/22/2022 8:56:38 PM

Friday, July 22, 2022 8:56:38 PM

Post# of 462842
Crescenmotor.....SAVA has a real challenge with all the recent bad press on their drug. Also with the very negative press on the amyloid plaque MOA, Anavex 2-73 has the data and should be able to step up to the in the next few months. Biospace needs to see us standing very close off stage!

----

https://www.biospace.com/article/claims-of-data-fabrication-could-set-alzheimer-s-research-back-by-almost-two-decades/?utm_campaign=Newsletter%20%7C%20GenePool&utm_medium=email&_hsmi=220500726&_hsenc=p2ANqtz-9GbK4LCD4eIQQpbW5R-NPcT9vKyY01n_AInsGnnktPYTcZUvOg0EkgZrkS7z8YO_Ul3wUAC5K_L7R3ZdcgebcDT13muw&utm_content=220500726&utm_source=hs_email
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News